Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model

Vaccine

Volumn 26, Issue 46, 2008, Pages 5864-5873

  Yandar, Nubia ^a   Pastorin, Giorgia ^b   Prato, Maurizio ^c   Bianco, Alberto ^b   Patarroyo, Manuel Elkin ^a,d,e   Manuel Lozano, José ^a,d,e  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF TRIESTE   (Italy)

^d FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Apical membrane antigen 1 (AMA 1); Functionalized carbon nanotubes (f CNT); Synthetic vaccine delivery system

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CARBON NANOTUBE; DRUG CARRIER; POLYCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; FEMALE; IMMUNE SYSTEM; IMMUNOGENICITY; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM VIVAX; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; CYTOKINES; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, MHC CLASS II; HLA-DR ANTIGENS; MALARIA; MALARIA VACCINES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; NANOTUBES; PLASMODIUM BERGHEI; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; VACCINES, SUBUNIT;

EID: 53449093079     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.014     Document Type: Article

References (37)

1. Bai T., Becker M., Gupta A., Strike P., Murphy V.J., Anders R.F., et al. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci USA 102 36 (2005) 12736-12741
2. Cheng Q., and Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol Biochem Parasitol 65 1 (1994) 183-187
3. Kocken C.H., Withers-Martinez C., Dubbeld M.A., van der Wel A., Hackett F., Valderrama A., et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 70 8 (2002) 4471-4476
4. Howell S.A., Withers-Martinez C., Kocken C.H., Thomas A.W., and Blackman M.J. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem 276 33 (2001) 31311-31320
5. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J., et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271 46 (1996) 29446-29452
6. Crewther P.E., Culvenor J.G., Silva A., Cooper J.A., and Anders R.F. Plasmodium falciparum: two antigens of similar size are located in different compartments of the rhoptry. Exp Parasitol 70 (1990) 193-206
7. Howell S.A., Well I., Fleck S.L., Kettleborough C., Collins C.R., and Blackman M.J. A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. J Biol Chem 278 26 (2003) 23890-23898
8. Silvie O., Franetich J.F., Charrin S., Mueller M.S., Siau A., Bodescot M., et al. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 279 10 (2004) 9490-9496
9. Rodrigues M.H., Rodrigues K.M., Oliveira T.R., Comodo A.N., Rodrigues M.M., Kocken C.H., et al. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol 35 2 (2005) 185-192
10. Healer J., Triglia T., Hodder A.N., Gemmill A.W., and Cowman A.F. Functional analysis of Plasmodium falciparum apical membrane antigen 1 utilizing interspecies domains. Infect Immun 73 4 (2005) 2444-2451
11. Saul A., Lawrence G., Allworth A., Elliott S., Anderson K., Rzepczyk C., et al. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine 23 23 (2005) 3076-3083
12. Chesne-Seck M.L., Pizarro J.C., Vulliez-Le Normand B., Collins C.R., Blackman M.J., Faber B.W., et al. Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol Biochem Parasitol 144 1 (2005) 55-67
13. Kam N.W., Liu Z., and Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl 45 4 (2006) 577-581
14. Kam N.W., and Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 127 16 (2005) 6021-6026
15. Pantarotto D., Briand J.P., Prato M., and Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) 1 (2004) 16-17
16. Bianco A., Kostarelos K., Partidos C.D., and Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 5 (2005) 571-577
17. Bianco A., Kostarelos K., and Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9 6 (2005) 674-679
18. Pantarotto D., Partidos C.D., Graff R., Hoebeke J., Briand J.P., Prato M., et al. Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc 125 20 (2003) 6160-6164
19. Pantarotto D., Partidos C.D., Hoebeke J., Brown F., Kramer E., Briand J.P., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 10 10 (2003) 897-898
20. Kreier J.P. Parasitic Protozoa (1991), Academic Press, New York
21. http://www.lumc.nl/1040/research/malaria/model102.html.
22. Merrifield R.B. Solid phase peptide synthesis I The synthesis of a tetrapeptide. J Am Chem Soc 85 (1963) 2149-2154
23. Tam J.P., Heath W.F., and Merrifield R.B. SN 1 and SN 2 mechanisms for the deprotection of synthetic peptides by hydrogen fluoride. Studies to minimize the tyrosine alkylation side reaction. Int J Pept Protein Res 21 (1983) 57-65
24. Houghten R.A. General method for the rapid solid phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci 82 (1985) 5131-5135
25. Georgakilas V., Tagmatarchis N., Pantarotto D., Bianco A., Briand J.P., and Prato M. Amino acid functionalisation of water soluble carbon nanotubes. Chem Commun (Camb) 24 (2002) 3050-3051
26. Kostarelos K., Lacerda L., Pastorin G., Wu W., Wieckowski S., Luangsivilay J., et al. Functionalised carbon nanotube cellular uptake and internalisation mechanism is independent of functional group and cell type. Nat Nanotech 2 (2007) 108-113
27. Mueller M.S., Renard A., Boato F., Vogel D., Naegeli M., Zurbriggen R., et al. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immun 71 8 (2003) 4749-4758
28. http://npsa-pbil.ibcp.fr.
29. in het Panhuis M. Vaccine delivery by carbon nanotubes. Chem Biol 10 10 (2003) 897-898
30. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., and Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 43 3 (2006) 193-201
31. Kocken C.H., Dubbeld M.A., Van Der Wel A., Pronk J.T., Waters A.P., Langermans J.A., et al. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect Immun 67 1 (1999) 43-49
32. Peterson M.G., Marshal V.M., Smythe J.A., Crewther P.E., Lew A., Silva A., et al. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol Cell Biol 9 7 (1989) 3151-3154
33. Healer J., Crawford S., Ralph S., McFadden G., and Cowman A.F. Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect Immun 70 10 (2002) 5751-5758
34. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L., Pollock B., et al. Immunisation with recombinant AMA-l protects mice against infection with Plasmodium chabaudi. Vaccine 16 2-3 (1998) 240-247
35. Kawamoto Y., Kojima K., Hitsumoto Y., Okada H., Holers V.M., and Miyama A. The serum resistance of malaria-infected erythrocytes. Immunology 91 1 (1997) 7-12
36. Castes M., and Tapia F. Inmunología de la Leishmaniasis tegumentaria Americana. Instituto de Biomedicina. Laboratorio de Biología Molecular-Venezuela (2005)
37. Marsh K., and Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 28 1-2 (2006) 51-60